What tests are required for diagnosing lupus erythematosus?

Diagnosing systemic lupus erythematosus (SLE) requires a comprehensive evaluation, including complete blood count (CBC), urinalysis, autoantibody testing, inflammatory marker assessment, and organ function evaluation. Integrating findings from these tests with clinical symptoms enables accurate diagnosis, assessment of disease activity, and determination of organ involvement. Individuals experiencing suspected symptoms should seek prompt medical evaluation and screening.

1. Complete Blood Count (CBC): CBC assesses quantitative changes in white blood cells, red blood cells, and platelets. SLE frequently causes cytopenias—such as leukopenia, anemia, and thrombocytopenia—leading to symptoms like fatigue, anemia, and impaired immunity. This test provides initial insight into whether the hematologic system is affected by the disease.

2. Urinalysis: Urinalysis primarily screens for urinary protein, red blood cells, and casts to evaluate renal involvement. Lupus nephritis—a common and serious complication of SLE—often develops silently; early abnormalities in urine parameters may occur without overt symptoms, making urinalysis a fundamental screening tool for detecting organ damage.

3. Autoantibody Testing: Autoantibody testing is a cornerstone of SLE diagnosis, enabling detection of disease-specific immunoglobulins. A positive result for characteristic autoantibodies—such as antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), and anti-Smith (anti-Sm) antibodies—provides critical diagnostic evidence and helps differentiate SLE from other rheumatic and autoimmune disorders, thereby enhancing diagnostic accuracy.

4. Inflammatory Marker Assessment: This includes tests such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), which reflect systemic inflammatory activity. Elevated levels indicate active disease flares and assist clinicians in gauging disease severity, guiding decisions regarding anti-inflammatory and immunomodulatory therapies.

5. Organ Function Evaluation: This encompasses assessments of hepatic and renal function, as well as cardiac and pulmonary evaluations, to comprehensively screen for multi-organ involvement. As a systemic autoimmune disorder, SLE can affect virtually any organ system; this evaluation clarifies the extent and severity of organ damage.

In daily life, individuals with SLE should practice rigorous sun protection, avoid sleep deprivation and excessive physical strain, prevent infections, maintain a balanced and regular diet and sleep schedule, stabilize immune function, and undergo routine follow-up testing—to effectively control disease progression.